Stryker Corporation
Stryker sells hip and knee implants, instruments, and an operating-room system called Mako. Zimmer and Johnson & Johnson sell implants in the same trade. Medtronic sells other devices. It is not the owner of the market by decree. This report does not describe the procedure or the implant.
The implant and the system are not the same book. The hospital can order the next one from someone else. Changing equipment is a project. A year of a high hospital budget is not normal earnings.
Cash separates the implant from the system. The dividend has to fit. It is not a surgeon who cannot change brand.
"The advantage is the hospital that already buys that implant and the team that already knows the system. They can order the next one elsewhere. The moat narrows if the budget falls, or if the system does not turn into more implants."
Loading the Vaultflake…
—
Health is the debt of two books, implant and system, not of a barrier already closed. Quality separates the implant margin from the system's. Growth follows hospital purchases, not a year of a high budget. P/E is read against a year of many sales, not against that peak. Shareholder return is the dividend, checked against cash. Do not read it as the implant market already closed.
The P/E of a year of many sales is not the earnings if the hospital delays the purchase. EV/EBITDA is read without treating the system as if the implant could not be ordered elsewhere. Do not use Intuitive's multiple, which sells another system, as if the implant and that operating room were the same book. A dash if the SYK cache is cold.
Not advice on Stryker. Vaultflake does not describe the procedure or the implant, and does not treat the market as closed. Read the filings. A past dividend is not a right. The table is a snapshot, not a target price.
The advantage is the hospital that already buys that implant and the team that already knows the system. They can order the next one elsewhere. The moat narrows if the budget falls, or if the system does not turn into more implants.
Health is the debt of two books, implant and system, not of a barrier already closed. Quality separates the implant margin from the system's. Growth follows hospital purchases, not a year of a high budget. P/E is read against a year of many sales, not against that peak. Shareholder return is the dividend, checked against cash. Do not read it as the implant market already closed.
The P/E of a year of many sales is not the earnings if the hospital delays the purchase. EV/EBITDA is read without treating the system as if the implant could not be ordered elsewhere. Do not use Intuitive's multiple, which sells another system, as if the implant and that operating room were the same book. A dash if the SYK cache is cold.
Not advice on Stryker. Vaultflake does not describe the procedure or the implant, and does not treat the market as closed. Read the filings. A past dividend is not a right. The table is a snapshot, not a target price.
Health Care · Pharmaceuticals and Medical Devices
Health Care · Diabetes and Obesity Medicines
Health Care · Insurance and Optum
Health Care · Diabetes and Obesity Medicines
Health Care · Immunology
Health Care · Oncology
A free account opens the interactive chart. The Vault assistant is Premium.